Although the drug is commonly used to treat hepatorenal syndrome in other parts of the world, it lacks FDA approval. Researchers examine both its efficacy and safety.
What about the kidneys make them a hotspot for COVID-19’s cytokine storm? A research team says it’s the presence of a protein found on specialized renal transport cells.
Pediatric hospitalizations for chronically ill children with kidney disease were associated with longer hospital stays, higher costs and a higher risk of mortality compared to other chronic illnesses
A new observational study finds patients in the hospital for COVID-19 have high levels of soluble urokinase receptor (suPAR), an immune-derived pathogenic protein that is strongly predictive of kidney injury.
A new study assesses the impact of bariatric surgery on patients with end stage kidney disease.